カテゴリー： QYResearch, 世界

血栓溶解薬の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Thrombolytic Drug Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X19031）・商品コード：DATA909X19031
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、血栓溶解薬の世界市場について調査・分析し、血栓溶解薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（フィブリン特異的薬物、非フィブリン特異的薬物シブ、シムツズマブ、INCB-39110、その他）、用途別（病院薬局、小売薬局、電子薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の血栓溶解薬市場動向
・主要企業別マーケットシェア
・血栓溶解薬の種類別市場規模2014-2019
（フィブリン特異的薬物、非フィブリン特異的薬物シブ、シムツズマブ、INCB-39110、その他）
・血栓溶解薬の用途別市場規模2014-2019
（病院薬局、小売薬局、電子薬局）
・血栓溶解薬の北米市場：主要企業・種類別/用途別市場規模
・血栓溶解薬のヨーロッパ市場：主要企業・種類別/用途別市場規模
・血栓溶解薬の中国市場：主要企業・種類別/用途別市場規模
・血栓溶解薬の日本国内市場：主要企業・種類別/用途別市場規模
・血栓溶解薬の東南アジア市場：主要企業・種類別/用途別市場規模
・血栓溶解薬のインド市場：主要企業・種類別/用途別市場規模
・血栓溶解薬の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Roche、Sedico Pharmaceuticals、Eumedica、Genentech、Microbix、Medac、Mochida Pharmaceutical、Taj Pharmaceuticals、Wulfing Pharma GmbH）
・血栓溶解薬の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Thrombolytic drugs, which dissolve solid blood clots, are commonly used to treat clot complications such as acute myocardial infarction, pulmonary embolism, deep venous thrombosis, blocked catheters, and acute ischemic stroke.Urokinase, streptokinase and tissue plasminogen activator (tPA) are the basic thrombolytic agents available on the market for thrombolytic therapy.Divided into fibrin – specific drugs and non – fibrin – specific drugs.The fibrin-specific drug segment is further divided into tissue plasminogen activator, retiplase, tenaiplase, etc.Nonfibrin-specific drugs are subdivided into urokinase, streptokinase, and plasminogen activated complexes.In 2018, the global Thrombolytic Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Thrombolytic Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Thrombolytic Drug development in North America, Europe, China and Japan.

The key players covered in this study
Roche
Sedico Pharmaceuticals
Eumedica
Genentech
Microbix
Medac
Mochida Pharmaceutical
Taj Pharmaceuticals
Wulfing Pharma GmbH

Market segment by Type, the product can be split into
Fibrin Specific Drugs
Nonfibrin-specific Drugs

Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacies
Electronic Pharmacy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan

The study objectives of this report are:
To analyze global Thrombolytic Drug status, future forecast, growth opportunity, key market and key players.
To present the Thrombolytic Drug development in North America, Europe, China and Japan.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Thrombolytic Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Thrombolytic Drug Market Size Growth Rate by Type (2014-2025)
1.4.2 Fibrin Specific Drugs
1.4.3 Nonfibrin-specific Drugs
1.5 Market by Application
1.5.1 Global Thrombolytic Drug Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacies
1.5.4 Electronic Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Thrombolytic Drug Market Size
2.2 Thrombolytic Drug Growth Trends by Regions
2.2.1 Thrombolytic Drug Market Size by Regions (2019-2025)
2.2.2 Thrombolytic Drug Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Thrombolytic Drug Market Size by by Players
3.1.1 Global Thrombolytic Drug Revenue by by Players (2014-2019)
3.1.2 Global Thrombolytic Drug Revenue Market Share by by Players (2014-2019)
3.1.3 Global Thrombolytic Drug Market Concentration Ratio (CR5 and HHI)
3.2 Thrombolytic Drug Key Players Head office and Area Served
3.3 Key Players Thrombolytic Drug Product/Solution/Service
3.4 Date of Enter into Thrombolytic Drug Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Thrombolytic Drug Market Size by Type (2014-2019)
4.2 Global Thrombolytic Drug Market Size by Application (2014-2019)

5 North America
5.1 North America Thrombolytic Drug Market Size (2014-2019)
5.2 Thrombolytic Drug Key Players in North America
5.3 North America Thrombolytic Drug Market Size by Type
5.4 North America Thrombolytic Drug Market Size by Application

6 Europe
6.1 Europe Thrombolytic Drug Market Size (2014-2019)
6.2 Thrombolytic Drug Key Players in Europe
6.3 Europe Thrombolytic Drug Market Size by Type
6.4 Europe Thrombolytic Drug Market Size by Application

7 China
7.1 China Thrombolytic Drug Market Size (2014-2019)
7.2 Thrombolytic Drug Key Players in China
7.3 China Thrombolytic Drug Market Size by Type
7.4 China Thrombolytic Drug Market Size by Application

8 Japan
8.1 Japan Thrombolytic Drug Market Size (2014-2019)
8.2 Thrombolytic Drug Key Players in Japan
8.3 Japan Thrombolytic Drug Market Size by Type
8.4 Japan Thrombolytic Drug Market Size by Application

9 International Players Profiles
9.1 Roche
9.1.1 Roche Company Details
9.1.2 Company Description and Business Overview
9.1.3 Thrombolytic Drug Introduction
9.1.4 Roche Revenue in Thrombolytic Drug Business (2014-2019))
9.1.5 Roche Recent Development
9.2 Sedico Pharmaceuticals
9.2.1 Sedico Pharmaceuticals Company Details
9.2.2 Company Description and Business Overview
9.2.3 Thrombolytic Drug Introduction
9.2.4 Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business (2014-2019)
9.2.5 Sedico Pharmaceuticals Recent Development
9.3 Eumedica
9.3.1 Eumedica Company Details
9.3.2 Company Description and Business Overview
9.3.3 Thrombolytic Drug Introduction
9.3.4 Eumedica Revenue in Thrombolytic Drug Business (2014-2019)
9.3.5 Eumedica Recent Development
9.4 Genentech
9.4.1 Genentech Company Details
9.4.2 Company Description and Business Overview
9.4.3 Thrombolytic Drug Introduction
9.4.4 Genentech Revenue in Thrombolytic Drug Business (2014-2019)
9.4.5 Genentech Recent Development
9.5 Microbix
9.5.1 Microbix Company Details
9.5.2 Company Description and Business Overview
9.5.3 Thrombolytic Drug Introduction
9.5.4 Microbix Revenue in Thrombolytic Drug Business (2014-2019)
9.5.5 Microbix Recent Development
9.6 Medac
9.6.1 Medac Company Details
9.6.2 Company Description and Business Overview
9.6.3 Thrombolytic Drug Introduction
9.6.4 Medac Revenue in Thrombolytic Drug Business (2014-2019)
9.6.5 Medac Recent Development
9.7 Mochida Pharmaceutical
9.7.1 Mochida Pharmaceutical Company Details
9.7.2 Company Description and Business Overview
9.7.3 Thrombolytic Drug Introduction
9.7.4 Mochida Pharmaceutical Revenue in Thrombolytic Drug Business (2014-2019)
9.7.5 Mochida Pharmaceutical Recent Development
9.8 Taj Pharmaceuticals
9.8.1 Taj Pharmaceuticals Company Details
9.8.2 Company Description and Business Overview
9.8.3 Thrombolytic Drug Introduction
9.8.4 Taj Pharmaceuticals Revenue in Thrombolytic Drug Business (2014-2019)
9.8.5 Taj Pharmaceuticals Recent Development
9.9 Wulfing Pharma GmbH
9.9.1 Wulfing Pharma GmbH Company Details
9.9.2 Company Description and Business Overview
9.9.3 Thrombolytic Drug Introduction
9.9.4 Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business (2014-2019)
9.9.5 Wulfing Pharma GmbH Recent Development

10 Market Forecast 2019-2025
10.1 Market Size Forecast by Product (2019-2025)
10.2 Market Size Forecast by Application (2019-2025)
10.3 Market Size Forecast by Regions
10.4 North America
10.5 Europe
10.6 China
10.7 Japan

11 Analyst’s Viewpoints/Conclusions

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

List of Tables and Figures

Table Thrombolytic Drug Key Market Segments
Table Key Players Thrombolytic Drug Covered
Table Global Thrombolytic Drug Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Fibrin Specific Drugs Figures
Table Key Players of Fibrin Specific Drugs
Figuer Nonfibrin-specific Drugs Figures
Table Key Players of Nonfibrin-specific Drugs
Table Global Thrombolytic Drug Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Thrombolytic Drug Market Share by Application in 2018 & 2025
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacies Case Studies
Figure Electronic Pharmacy Case Studies
Figure Thrombolytic Drug Report Years Considered
Figure Global Thrombolytic Drug Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Thrombolytic Drug Market Size by Regions 2019-2025 (Million US$)
Table Global Thrombolytic Drug Market Size by Regions 2019-2025 (Million US$)
Table Global Thrombolytic Drug Market Share by Regions 2014-2019
Figure Global Thrombolytic Drug Market Share by Regions 2014-2019
Figure Global Thrombolytic Drug Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Thrombolytic Drug Revenue by by Players (2014-2019) (Million US$)
Table Global Thrombolytic Drug Market Share by by Players (2014-2019)
Figure Global Thrombolytic Drug Market Share by by Players in 2018
Table Global Thrombolytic Drug by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Thrombolytic Drug Product/Solution/Service
Table Date of Enter into Thrombolytic Drug Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Thrombolytic Drug Market Size by Type (2014-2019) (Million US$)
Table Global Thrombolytic Drug Market Size Share by Type (2014-2019)
Figure Global Thrombolytic Drug Market Size Market Share by Type (2014-2019)
Table Global Thrombolytic Drug Market Size by Application (2014-2019) (Million US$)
Table Global Thrombolytic Drug Market Size Share by Application (2014-2019)
Figure Global Thrombolytic Drug Market Size Market Share by Application (2014-2019)
Figure Global Thrombolytic Drug Revenue Market Share by Application in 2018
Figure North America Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table North America Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table North America Key Players Thrombolytic Drug Market Share (2018-2019)
Table North America Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table North America Thrombolytic Drug Market Share by Type 2014-2019
Table North America Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table North America Thrombolytic Drug Market Share by Application 2014-2019
Figure Europe Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table Europe Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table Europe Key Players Thrombolytic Drug Market Share (2018-2019)
Table Europe Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table Europe Thrombolytic Drug Market Share by Type 2014-2019
Table Europe Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table Europe Thrombolytic Drug Market Share by Application 2014-2019
Figure China Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table China Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table China Key Players Thrombolytic Drug Market Share (2018-2019)
Table China Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table China Thrombolytic Drug Market Share by Type 2014-2019
Table China Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table China Thrombolytic Drug Market Share by Application 2014-2019
Figure Japan Thrombolytic Drug Market Size 2014-2019 (Million US$)
Table Japan Key Players Thrombolytic Drug Revenue (2018-2019) (Million US$)
Table Japan Key Players Thrombolytic Drug Market Share (2018-2019)
Table Japan Thrombolytic Drug Market Size by Type 2014-2019 (Million US$)
Table Japan Thrombolytic Drug Market Share by Type 2014-2019
Table Japan Thrombolytic Drug Market Size by Application 2014-2019 (Million US$)
Table Japan Thrombolytic Drug Market Share by Application 2014-2019
Table Roche Company Details
Table Roche Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Roche Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Roche Recent Development
Table Sedico Pharmaceuticals Company Details
Table Sedico Pharmaceuticals Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Sedico Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Sedico Pharmaceuticals Recent Development
Table Eumedica Company Details
Table Eumedica Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Eumedica Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Eumedica Recent Development
Table Genentech Company Details
Table Genentech Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Genentech Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Genentech Recent Development
Table Microbix Company Details
Table Microbix Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Microbix Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Microbix Recent Development
Table Medac Company Details
Table Medac Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Medac Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Medac Recent Development
Table Mochida Pharmaceutical Company Details
Table Mochida Pharmaceutical Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Mochida Pharmaceutical Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Mochida Pharmaceutical Recent Development
Table Taj Pharmaceuticals Company Details
Table Taj Pharmaceuticals Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Taj Pharmaceuticals Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Taj Pharmaceuticals Recent Development
Table Wulfing Pharma GmbH Company Details
Table Wulfing Pharma GmbH Revenue in Thrombolytic Drug Business 2014-2019 (Million US$)
Figure Wulfing Pharma GmbH Revenue Growth Rate in Thrombolytic Drug Business (2014-2019)
Table Wulfing Pharma GmbH Recent Development
Table Global Thrombolytic Drug Market Size by Regions (Million US$) 2019-2025
Figure Global Thrombolytic Drug Market Size Share by Regions (2019-2025)
Figure Global Thrombolytic Drug Market Size Share by Regions in 2025
Figure North America Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Figure Europe Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Figure China Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Figure Japan Thrombolytic Drug Market Size Forecast (2019-2025)(Million USD)
Table Global Thrombolytic Drug Market Size by Product (2019-2025) (Million US$)
Figure Global Thrombolytic Drug Market Size by Product (2019-2025)
Figure Global Thrombolytic Drug Market Size by Product in 2025
Table Global Thrombolytic Drug Market Size by Application (2019-2025) (Million US$)
Figure Global Thrombolytic Drug Market Size by Application (2019-2025)
Figure Global Thrombolytic Drug Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche、Sedico Pharmaceuticals、Eumedica、Genentech、Microbix、Medac、Mochida Pharmaceutical、Taj Pharmaceuticals、Wulfing Pharma GmbH

★調査レポート[血栓溶解薬の世界市場：規模・現状・予測2019-2025] (コード：DATA909X19031)販売に関する免責事項を必ずご確認ください。
★調査レポート[血栓溶解薬の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 血栓溶解療法の世界市場：規模・現状・予測2019-2025
    DATA909X19032 / QYResearch / 2019年11月25日 / ※当調査レポートでは、血栓溶解療法の世界市場について調査・分析し、血栓溶解療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（薬物治療、外科治療、その他の治療）、用途別（急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル遮断、急性虚血性脳卒中）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の血栓溶解療法市場動向 ・主要企業別マーケットシェア ・血栓溶解療法の種類別市場規模2014-2019 （薬物治療、外科治療、その他の治療） ・血栓溶解療法の用途別市場規模2014-2019 （急性心筋梗塞、肺塞栓症、深部静脈血栓症、カテーテル遮断、急性虚血性脳卒中） ・血栓溶解療法の北米市場：主要企業・種類別/用途別市場規模 ・血栓溶解療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Blood clots are one of the most serious complications in the body.When blood clots, major arteries or veins become blocked, which stops normal blood flow.The cessation of normal blood flow can cause bleeding and often leads to heart attacks and strokes.Thrombolytic therapy is a treatment in which solid blood clots are dissolved by administration of thrombolytic drugs.The length of treatment depends on the type or degree of complication.In the case of a heart attack, treatment may take up to an hour, or 48 hours in the case of a deep vein thrombosis.Brain CT test, electrocardiogram and electroencephalogram are effective methods...
  • 創薬ソフトウェアの世界市場：規模・現状・予測2019-2025
    DATA909X18408 / QYResearch / 2019年11月25日 / ※当調査レポートでは、創薬ソフトウェアの世界市場について調査・分析し、創薬ソフトウェアの世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（クラウドベース、ウェブベース）、用途別（CRO及び大学、企業、試験研究所）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の創薬ソフトウェア市場動向 ・主要企業別マーケットシェア ・創薬ソフトウェアの種類別市場規模2014-2019 （クラウドベース、ウェブベース） ・創薬ソフトウェアの用途別市場規模2014-2019 （CRO及び大学、企業、試験研究所） ・創薬ソフトウェアの北米市場：主要企業・種類別/用途別市場規模 ・創薬ソフトウェアのヨーロッパ市場：主要企業・種類別/用途別市場規模...In 2018, the global Drug Discovery Software market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Drug Discovery Software status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Drug Discovery Software development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Epocrates MicroTracker DrugPatentWatch PEPID PDC AtomWise InSilicoTrials Thermo Scientific AutoDock CCD Vault Compound Assist DrugDev...

    • ◆H&Iグローバルリサーチのお客様（例）◆